Cytomegalovirus Disease Prevention

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2017-11-17
Clinical Trial Update: Letermovir (MK-8228) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001) [Phase 3]
Phase 3 trial evaluating letermovir versus placebo for preventing clinically significant CMV infection in CMV-seropositive adult allogeneic …